1 / 25

Fikri M Abu-Zidan, MD, FRCS, PhD, DipApplStats Statistics Editor, Emirates Medical Journal,

120. 100. 80. 60. 40. 20. 0. 0. 10. 20. 30. 40. 50. Statistics: When and how?. Fikri M Abu-Zidan, MD, FRCS, PhD, DipApplStats Statistics Editor, Emirates Medical Journal, Associate Professor, Head, Trauma Group, Faculty of Medicine and Health Sciences, UAE University.

Download Presentation

Fikri M Abu-Zidan, MD, FRCS, PhD, DipApplStats Statistics Editor, Emirates Medical Journal,

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. 120 100 80 60 40 20 0 0 10 20 30 40 50 Statistics: When and how? Fikri M Abu-Zidan, MD, FRCS, PhD, DipApplStats Statistics Editor, Emirates Medical Journal, Associate Professor, Head, Trauma Group, Faculty of Medicine and Health Sciences, UAE University

  2. Statistics is a branch of mathematics dealing with the collection, analysis and interpretation of masses of numerical data. Merriam- Webster 1997 It is a tool to summarize and compare data in an informative way and not an aim by itself. It can not replace proper research questions. Fishing for questions to fit the data after analyzing it is erroneous.

  3. Questions to be answered What is the objective of the analysis? Define the research question before starting the analysis What is the type of the data? How many groups are there? One group Two groups More than two groups Are the data normally distributed? If not, either transform data or use non parametric methods Are the groups related or unrelated?

  4. Types of data Type Example Categorical data Color of the eye Binomial data Gender Ordinal Likert Scale Interval Weight

  5. Conclusions depend on • Difference between the means • 2) Variability of the results Variance n x1 x x3 x2 x4 Variance: ∑ (x-x)2 n-1 x5 Standard deviation (SD) = xn SD Standard Error (SE) =

  6. Group 2 Group 1 60 65 70 75 80 85 90 95 Weight (kg) Assumptions involved in t testing 1) Normal distribution 2) Same variability

  7. 68.26% 15.87% 15.87% +1 SD -1 SD 0

  8. 95 % 2.5 % 2.5 % +1.96 SD -1.96 SD 0

  9. Females Males 150 155 160 165 170 175 180 185 Height (cm)

  10. Males Females 150 155 160 165 170 175 180 185 Height (cm)

  11. Males Sample size 100 10 2 1 160 165 170 175 180 185 190 Height (cm)

  12. We would not expect the actual differences to be more than approximately 2 standard errors away from zero, assuming, of course, that the results follows a normal distribution. 95% of all non-genuine differences will lie between ± 2 standard errors.

  13. Null hypothesis The two groups being compared are assumed the same until proven different. A large sample difference suggest a real difference is inherently more appealing than the remote (5%) (Type I error), p < 0.05 An innocent verdict does not necessarily mean that a jury is convinced of a defendant’s innocence. It may mean that the facts were not strong enough. (Type II error)

  14. Two-tailed test Differences in either direction The standard way of comparison One-tailed test Decided before analysis Justified by the logic of comparison Clearly identified in report

  15. Paired t-test Pairs can be formed on natural basis (twin) or on a more arbitrary artificial basis.  Beware Do not analyze the results of a paired experiment using an independent t test. This ignores the paired nature of the results and loses the advantages of this very sensitive test.

  16. Do not look through the p pinhole t = 8/2 = 4 P < 0.05 Placebo n=100 mean (SEM) 120 (2) mmHg New drug n=100 mean (SEM) 112 (2) mmHg

  17. 140 120 120 100 100 80 80 60 60 40 40 20 20 0 0 1 2 3 4 5 6 7 8 0 10 20 30 40 50 2 Mean Transformation Mean

  18. ** 60 ** 55 50 45 40 Amylin pM 35 30 25 20 15 10 Control Sham Ischaemia operated reperfusion

  19. 130 110 ** MAP mmHg 90 ** S group, n=10 IR group, n=10 70 50 20 40 60 80 0 Time (Minutes)

  20. Report 1.The number of each group 2.The mean value of each group 3.The standard deviation of each group 4.The range of results 5.The calculated value of t 6.The degree of freedom involved 7.The type I error involved

  21. Checklist What is the null hypothesis? What is the alternative hypothesis (two-tailed or one-tailed test) ? Are the two sets of results unrelated to one another? What is the critical value? 5 % if you are carrying out a two-tailed test 10% if you are carrying out a one-tailed test Does the t value exceeds the critical value?

  22. Correlations 6.5 Spearman Rank Correlation 6 Average of 15 questions 5.5 r = 0.84 p = 0.0002 5 4.5 4 5 6 7 Overall rating

  23. Thank You

More Related